Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling

Lung metastasis represents the leading cause of osteosarcoma-related death. Progress in preventing lung metastasis is pretty modest due to the inherent complexity of the metastatic process and the lack of suitable models. Herein, we provide mechanistic insights into how osteosarcoma systemically reprograms the lung microenvironment for metastatic outgrowth using metastatic mouse models and a multi-omics approach. We found that osteosarcoma-bearing mice or those preconditioned with cell-secretome harbour profound lung structural alteration with airways damage, inflammation, neutrophil infiltration, and remodelling of the extracellular matrix with deposition of fibronectin and collagen by stromal activated fibroblasts for tumour cell adhesion. These changes, supported by transcriptomic and histological data, promoted and accelerated the development of lung metastasis. Comparative proteome profiling of the cell secretome and mouse plasma identified a large number of proteins engaged in the extracellular-matrix organization, cell-matrix adhesion, neutrophil degranulation, and cytokine-mediated signalling, which were consistent with the observed lung microenvironmental changes. Moreover, we identified EFEMP1, a secreted extracellular matrix glycoprotein, as a potential risk factor for lung metastasis and a poor prognosis factor in osteosarcoma patients.

[1]  Shanshan Yang,et al.  Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments , 2023, Molecular Cancer.

[2]  A. Falcão,et al.  Osteosarcoma-Derived Exosomes as Potential PET Imaging Nanocarriers for Lung Metastasis. , 2022, Small.

[3]  D. Zhang,et al.  EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways , 2022, Journal of bone oncology.

[4]  S. Razi,et al.  The pro-tumorigenic responses in metastatic niches: an immunological perspective , 2022, Clinical and Translational Oncology.

[5]  F. Verrecchia,et al.  Origin and Therapies of Osteosarcoma , 2022, Cancers.

[6]  Ali Al Khader,et al.  Significance of fibulin-3 expression in bladder cancer: a tissue microarray-based immunohistochemical study , 2022, World Journal of Surgical Oncology.

[7]  C. Hawkins,et al.  Recent and Ongoing Research into Metastatic Osteosarcoma Treatments , 2022, International journal of molecular sciences.

[8]  Y. Shao,et al.  High expression of the ferroptosis‐associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma , 2022, Journal of clinical laboratory analysis.

[9]  M. Jücker,et al.  The Functional Role of Extracellular Matrix Proteins in Cancer , 2022, Cancers.

[10]  Yong Yang,et al.  Osteosarcoma and Metastasis , 2021, Frontiers in Oncology.

[11]  Z. Shao,et al.  ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression , 2021, Cancer Research.

[12]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[13]  R. Sharan,et al.  Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity , 2021, eLife.

[14]  T. Chan,et al.  Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma , 2021, Genes.

[15]  P. Papageorgis,et al.  The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities , 2021, Cancers.

[16]  Q. Ji,et al.  Underlying mechanisms and drug intervention strategies for the tumour microenvironment , 2021, Journal of experimental & clinical cancer research : CR.

[17]  L. Qin,et al.  Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways , 2021, Molecular Biomedicine.

[18]  Shih-Ying Wu,et al.  Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung , 2021, Nature Communications.

[19]  Hongmei Zhou,et al.  Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts , 2020, Biomolecules.

[20]  B. Fuchs,et al.  Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model , 2020, Cancers.

[21]  Z. Werb,et al.  Concepts of extracellular matrix remodelling in tumour progression and metastasis , 2020, Nature Communications.

[22]  B. Fuchs,et al.  Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming , 2020, International journal of molecular sciences.

[23]  Jianqing Gao,et al.  Prognosis and targeting of pre-metastatic niche. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[24]  M. Lindsey,et al.  Fibroblasts: The arbiters of extracellular matrix remodeling. , 2020, Matrix biology : journal of the International Society for Matrix Biology.

[25]  Natasha Kolesnikoff,et al.  ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism , 2020, Nature Cell Biology.

[26]  A. Schneeweiss,et al.  Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs , 2020, Nature Communications.

[27]  P. Houghton,et al.  Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease , 2020, Oncotarget.

[28]  T. Fan,et al.  Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression , 2020, Frontiers in Oncology.

[29]  Xin Hu,et al.  IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability , 2019, Advanced science.

[30]  M. Minopoli,et al.  Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy , 2019, Front. Oncol..

[31]  Jessica Burns,et al.  Proteomic research in sarcomas – current status and future opportunities , 2019, Seminars in cancer biology.

[32]  V. Barnaba,et al.  Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure , 2019, Clinical Proteomics.

[33]  Lungen Lu,et al.  Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B) , 2019, Cancer medicine.

[34]  J. Lee,et al.  SERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types , 2019, Cancers.

[35]  B. Molon,et al.  Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization , 2018, International journal of molecular sciences.

[36]  Christopher S. Hughes,et al.  Single-pot, solid-phase-enhanced sample preparation for proteomics experiments , 2018, Nature Protocols.

[37]  A. Ray,et al.  Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma , 2018, Scientific Reports.

[38]  Y. Aratani Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. , 2018, Archives of biochemistry and biophysics.

[39]  E. Chiffoleau,et al.  C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets , 2018, Front. Immunol..

[40]  Ronit Vogt Sionov,et al.  The regulation of pre-metastatic niche formation by neutrophils , 2017, Oncotarget.

[41]  Thomas R. Cox,et al.  Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.

[42]  Ying Chang,et al.  Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand. , 2017, International journal of oncology.

[43]  G. Stein,et al.  Proteomic Analysis of Exosomes and Exosome‐Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression , 2016, Journal of cellular biochemistry.

[44]  Dongxi Xiang,et al.  Prognostic value of inflammation-based scores in patients with osteosarcoma , 2016, Scientific Reports.

[45]  P. Forget,et al.  The neutrophil-to-lymphocyte ratio: a narrative review , 2016, Ecancermedicalscience.

[46]  Xuetao Cao,et al.  Characteristics and Significance of the Pre-metastatic Niche. , 2016, Cancer cell.

[47]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[48]  R. Kalluri The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[49]  R. Gomis,et al.  Tumour stroma‐derived lipocalin‐2 promotes breast cancer metastasis , 2016, The Journal of pathology.

[50]  C. Tripodo,et al.  C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation , 2016, Nature Communications.

[51]  H. Vogel,et al.  Lubricin/Proteoglycan 4 binds to and regulates the activity of Toll-Like Receptors In Vitro , 2016, Scientific Reports.

[52]  Davalyn R. Powell,et al.  Neutrophils in the Tumor Microenvironment. , 2016, Trends in immunology.

[53]  G. Jay,et al.  The interaction of lubricin/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid , 2015, Arthritis Research & Therapy.

[54]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[55]  P. Meltzer,et al.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  James J. Morrow,et al.  Characterization of the metastatic phenotype of a panel of established osteosarcoma cells , 2015, Oncotarget.

[57]  Lian-tang Wang,et al.  EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway , 2015, Oncotarget.

[58]  A. Luster,et al.  The chemokine system in innate immunity. , 2015, Cold Spring Harbor perspectives in biology.

[59]  Z. Werb,et al.  Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.

[60]  Zhihua Liu,et al.  S100 protein family in human cancer. , 2014, American journal of cancer research.

[61]  Guoxiong Xu,et al.  Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway , 2014, International journal of oncology.

[62]  J. Weiss,et al.  TGF-β signaling in myeloid cells is required for tumor metastasis. , 2013, Cancer discovery.

[63]  A. Möller,et al.  The pre-metastatic niche: finding common ground , 2013, Cancer and Metastasis Reviews.

[64]  T. He,et al.  The Current and Future Therapies for Human Osteosarcoma. , 2013, Current cancer therapy reviews.

[65]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[66]  J. V. Van Eyk,et al.  Secreted proteins as a fundamental source for biomarker discovery , 2012, Proteomics.

[67]  Sandrine Dudoit,et al.  GC-Content Normalization for RNA-Seq Data , 2011, BMC Bioinformatics.

[68]  L. Norton,et al.  Tumor entrained neutrophils inhibit seeding in the premetastatic lung. , 2011, Cancer cell.

[69]  Marcel Martin Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[70]  Cedric E. Ginestet ggplot2: Elegant Graphics for Data Analysis , 2011 .

[71]  Thijs J. Hagenbeek,et al.  Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes , 2010, Proceedings of the National Academy of Sciences.

[72]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[73]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[74]  Bin Hu,et al.  Fibulin-3 Is Uniquely Upregulated in Malignant Gliomas and Promotes Tumor Cell Motility and Invasion , 2009, Molecular Cancer Research.

[75]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[76]  Robert Gentleman,et al.  ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data , 2009, Bioinform..

[77]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[78]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[79]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[80]  M. Lai,et al.  The cancer secretome: a reservoir of biomarkers , 2008, Journal of Translational Medicine.

[81]  R. Kaplan,et al.  Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond , 2007, Cancer and Metastasis Reviews.

[82]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[83]  Guangwu Xu,et al.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know , 2006, Cell Research.

[84]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[85]  R. Timpl,et al.  Fibulins: a versatile family of extracellular matrix proteins , 2003, Nature Reviews Molecular Cell Biology.